Gain Therapeutics Inc logo

Gain Therapeutics Inc share price today

(GANX)

Gain Therapeutics Inc share price is $1.79 & ₹151.58 as on 9 Dec 2024, 20.00 hrs IST

$1.79

0.08

(4.68%)

Market is closed - opens 8 PM, 09 Dec 2024

View live Gain Therapeutics Inc share price in Dollar and Rupees. Guide to invest in Gain Therapeutics Inc from India. Also see the sentimental analysis on Indian investors investing in Gain Therapeutics Inc. Get details on the Indian mutual funds that are investing in Gain Therapeutics Inc. Get Analyst recommendations and forecasts along with all the Gain Therapeutics Inc's financials.

Gain Therapeutics Inc share price movements

  • $1.68
    $1.84

    Day's Volatility :8.52%

  • $0.89
    $5.33

    52 Weeks Volatility :83.3%

Gain Therapeutics Inc Returns

PeriodGain Therapeutics IncIndex (Russel 2000)
3 Months
47.41%
0.0%
6 Months
-18.18%
0.0%
1 Year
-34.48%
0.0%
3 Years
-71.5%
-20.3%

Gain Therapeutics Inc Key Statistics

in dollars & INR

Previous Close
$1.79
Open
$1.8
Today's High
$1.8311
Today's Low
$1.8
Market Capitalization
$48.8M
Today's Volume
$241.7K
52 Week High
$5.33
52 Week Low
$0.89
Revenue TTM
$0.0
EBITDA
$-21.8M
Earnings Per Share (EPS)
$-1.24
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-188.83%

How to invest in Gain Therapeutics Inc from India?

It is very easy for Indian residents to invest directly in Gain Therapeutics Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Gain Therapeutics Inc stock in both rupees (INR) and dollars (USD). Search for Gain Therapeutics Inc or GANX on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Gain Therapeutics Inc or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Gain Therapeutics Inc shares which would translate to 0.473 fractional shares of Gain Therapeutics Inc as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Gain Therapeutics Inc

-14%

Period: Sep 9, 2024 to Dec 8, 2024. Change in 30 Days versus previous period

Search volume for Gain Therapeutics Inc on INDmoney from India has reduced in the last 30 days as on Dec 9, 2024. -14% less investors are searching Gain Therapeutics Inc in the last 30 days versus the previous period.

Global Institutional Holdings in Gain Therapeutics Inc

  • Gotham Asset Management, LLC

    1.26%

  • HOHIMER WEALTH MANAGEMENT, LLC

    1.24%

  • Geode Capital Management, LLC

    1.03%

  • Vanguard Group Inc

    0.55%

  • BlackRock Inc

    0.32%

  • Renaissance Technologies Corp

    0.20%

Analyst Recommendation on Gain Therapeutics Inc

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Gain Therapeutics Inc(by analysts ranked 0 to 5 stars)

Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
10
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Gain Therapeutics Inc

What analysts predicted

Upside of 313.41%

Current:

$1.79

Target:

$7.40

Insights on Gain Therapeutics Inc

  • Price Movement

    In the last 1 month, GANX stock has moved down by -22.8%
  • GANX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 48.1% return, outperforming this stock by 85.2%
  • GANX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 46.0% return, outperforming this stock by 117.5%

Gain Therapeutics Inc Technicals Summary

Sell

Neutral

Buy

Gain Therapeutics Inc is currently in a neutral trading position according to technical analysis indicators.

Gain Therapeutics Inc Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Gain Therapeutics Inc
-21.2%
-18.18%
-34.48%
-71.5%
-84.73%
Regeneron Pharmaceuticals, Inc.
-7.0%
-23.34%
-9.49%
14.69%
105.58%
Biontech Se
9.3%
21.29%
18.26%
-53.88%
279.68%
Alnylam Pharmaceuticals, Inc.
-10.01%
64.08%
47.33%
45.01%
111.98%
Vertex Pharmaceuticals Incorporated
-8.33%
-4.83%
29.09%
121.05%
109.05%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Gain Therapeutics Inc
NA
NA
NA
-0.97
-1.89
-0.73
NA
0.78
Regeneron Pharmaceuticals, Inc.
18.56
18.56
1.12
44.92
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.06
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.21
0.54
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Gain Therapeutics Inc
Buy
$48.8M
-84.73%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$82.9B
105.58%
18.56
33.61%
Biontech Se
Buy
$28.5B
279.68%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$32.7B
111.98%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$118.4B
109.05%
32.84
-4.51%

About Gain Therapeutics Inc

gain therapeutics is a preclinical stage biotech company specializing in the discovery of new drugs for orphan diseases. the company targets inborn errors of metabolism; a group of rare diseases of genetic origin with a high unmet medical need. gain therapeutics is also working on a new class of compounds: non-competitive pharmacological chaperones, identified through its innovative proprietary platform – see-tx. the gain therapeutics team is made up of a group of drug discovery and development experts with several decades of experience in biotech and pharma.
Organization
Gain Therapeutics Inc
Employees
29
CEO
Dr. Khalid Islam Ph.D.
Industry
Miscellaneous

Management People of Gain Therapeutics Inc

NameTitle
Dr. Khalid Islam Ph.D.
Executive Chairman
Mr. Gene Mack M.B.A.
CFO & Interim CEO
Dr. Joanne Taylor Ph.D.
Senior Vice President of Research
Dr. Terenzio Ignoni Pharm.D.
Senior Vice President of Technical Operations
Dr. Jonas Hannestad M.D., Ph.D.
Chief Medical Officer

Important FAQs about investing in Gain Therapeutics Inc from India :

What is Gain Therapeutics Inc share price today?

Gain Therapeutics Inc (GANX) share price today is $1.79.

Can Indians buy Gain Therapeutics Inc shares?

Yes, Indians can invest in the Gain Therapeutics Inc (GANX) from India.

With INDmoney, you can buy Gain Therapeutics Inc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Gain Therapeutics Inc at zero transaction cost.

How can I buy Gain Therapeutics Inc shares from India?

It is very easy to buy Gain Therapeutics Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Gain Therapeutics Inc be purchased?

Yes, you can buy fractional shares of Gain Therapeutics Inc with INDmoney app.

What are the documents required to start investing in Gain Therapeutics Inc stocks?

To start investing in Gain Therapeutics Inc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Gain Therapeutics Inc

Today’s highest price of Gain Therapeutics Inc (GANX) is $1.84.

Today’s lowest price of Gain Therapeutics Inc (GANX) is $1.68.

What is today's market capitalisation of Gain Therapeutics Inc

Today's market capitalisation of Gain Therapeutics Inc GANX is 48.8M

What is the 52 Week High and Low Range of Gain Therapeutics Inc

  • 52 Week High

    $5.33

  • 52 Week Low

    $0.89

How much percentage Gain Therapeutics Inc is down from its 52 Week High?

Gain Therapeutics Inc (GANX) share price is $1.79. It is down by 66.42% from its 52 Week High price of $5.33.

How much percentage Gain Therapeutics Inc is up from its 52 Week low?

Gain Therapeutics Inc (GANX) share price is $1.79. It is up by 101.12% from its 52 Week Low price of $0.89.

What are the historical returns of Gain Therapeutics Inc?

  • 1 Month Returns

    -21.2%

  • 3 Months Returns

    -18.18%

  • 1 Year Returns

    -34.48%

  • 5 Years Returns

    -84.73%

Who is the Chief Executive Officer (CEO) of Gain Therapeutics Inc

Dr. Khalid Islam Ph.D. is the current Chief Executive Officer (CEO) of Gain Therapeutics Inc.